word
count
use
licens
abstract
background
caus
coronaviru
diseas
associ
respiratoryrel
morbid
mortal
assay
detect
virusspecif
antibodi
import
understand
preval
infect
cours
immun
respons
methodolog
quantit
measur
plasma
serum
antibodi
luciferas
immunoprecipit
assay
system
lip
nucleocapsid
spike
protein
analyz
crosssect
longitudin
sampl
patient
subset
sampl
test
without
heat
inactiv
result
fifteen
day
symptom
onset
antibodi
nucleocapsid
protein
show
sensit
specif
antibodi
spike
protein
detect
sensit
specif
neither
antibodi
level
rate
seroposit
significantli
reduc
heat
inactiv
sampl
analysi
daili
sampl
six
patient
show
antinucleocapsid
spike
antibodi
appear
day
day
initi
symptom
immunocompromis
patient
gener
delay
antibodi
respons
compar
immunocompet
patient
conclus
antibodi
nucleocapsid
protein
sensit
spike
protein
antibodi
detect
earli
infect
analyz
heatinactiv
sampl
lip
safe
sensit
method
detect
antibodi
infect
sever
acut
respiratori
syndrom
coronaviru
caus
coronaviru
diseas
first
report
china
major
clinic
featur
virusassoci
pneumon
unlik
highli
sever
group
report
serolog
diagnost
test
use
nucleocapsid
andor
spike
protein
elisa
immunofluoresc
even
later
flow
test
one
studi
use
elisa
measur
antibodi
nucleocapsid
protein
found
patient
becom
seroposit
day
onset
symptom
commerci
elisa
use
spike
protein
demonstr
igg
antibodi
detect
use
licens
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
median
day
onset
symptom
et
al
examin
antibodi
spike
nucleocapsid
elisa
small
number
sampl
found
igg
antibodi
nucleocapsid
protein
gener
detect
time
antibodi
spike
protein
despit
find
studi
need
better
understand
antibodi
dynam
person
infect
determin
sensit
specif
antibodi
assay
use
antibodybas
test
determin
seropreval
differ
popul
addit
current
unknown
whether
viral
rna
detect
blood
indic
presenc
infecti
viru
potenti
safeti
hazard
health
care
worker
clinic
laboratori
technician
research
analyz
serolog
person
infect
thu
sensit
specif
antibodi
assay
use
heat
treat
plasma
serum
may
enhanc
safeti
work
fluid
other
employ
liquid
phase
immunoassay
technolog
term
luciferas
immunoprecipit
system
lip
measur
antibodi
mani
differ
virus
stratifi
infect
patient
base
level
antibodi
viru
discoveri
rang
antigen
requir
ul
plasma
sera
test
recombin
nucleocapsid
spike
protein
antigen
lip
assay
use
licens
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
use
measur
antibodi
patient
four
geograph
dispar
locat
across
unit
state
lip
assay
show
high
sensit
specif
detect
antibodi
demonstr
nucleocapsid
antibodi
emerg
spike
antibodi
moreov
potenti
safeti
issu
relat
presenc
rna
blood
show
heat
inactiv
plasma
min
significantli
reduc
sensit
lip
assay
thu
allow
test
perform
safe
retrospect
studi
analyz
crosssect
longitudin
blood
sampl
collect
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
nih
clinic
center
bethesda
md
confirm
posit
rna
case
nih
sampl
serial
daili
blood
drawn
sampl
avail
cover
day
symptom
onset
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
compar
antibodi
detect
use
show
similar
result
former
construct
use
nucleocapsid
spike
proteinlight
emit
plasmid
construct
transfect
cell
lysat
harvest
hour
later
obtain
crude
cell
extract
test
heatinactiv
serum
plasma
sampl
dilut
assay
buffer
mm
tri
ph
mm
nacl
mm
triton
dilut
sampl
test
microtit
plate
describ
incub
room
temperatur
one
hour
mixtur
transfer
microtit
filter
plate
contain
data
percentag
categor
variabl
mean
rang
geometr
mean
plu
ci
use
describ
data
wilcoxon
sign
rank
use
statist
analysi
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
patient
locat
four
geograph
distinct
locat
across
unit
state
includ
case
confirm
pcr
subject
symptom
household
contact
person
test
pcr
blood
donor
donat
sampl
use
control
tabl
major
sar
pcrconfirm
case
male
median
age
year
rang
year
subset
pcrconfirm
case
one
risk
factor
includ
heart
diseas
lung
diseas
diabet
andor
immunocompromis
two
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
mean
plu
four
standard
deviat
lu
mean
plu
three
standard
deviat
lu
blood
donor
control
respect
evalu
sampl
collect
day
onset
symptom
show
reduc
sensit
specif
maintain
sensit
antibodi
nucleocapsid
protein
time
point
antibodi
detect
sampl
ucsd
uw
eh
nih
figur
orang
dot
analysi
spike
use
licens
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
antibodi
sampl
collect
day
onset
symptom
show
sensit
antibodi
detect
sampl
ucsd
sampl
uw
eh
nih
taken
togeth
find
indic
detect
antibodi
nucleocapsid
protein
sensit
detect
antibodi
spike
protein
nucleocapsid
antibodi
gener
appear
earlier
spike
antibodi
addit
pcrconfirm
patient
suspect
case
eh
also
analyz
seroposit
nine
ten
suspect
case
without
viral
pcr
confirm
show
symptom
compat
collect
januari
februari
seroneg
nucleocapsid
spike
antibodi
figur
interestingli
one
case
march
person
household
contact
pcr
patient
seroposit
nucleocapsid
spike
antibodi
sinc
interest
use
serolog
assay
assess
current
histor
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
respons
none
immunocompromis
patient
die
overal
result
small
group
patient
suggest
immunocompromis
patient
gener
attenu
andor
delay
antibodi
respons
immunocompet
patient
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
publish
assay
analysi
longitudin
plasma
sampl
show
antibodi
nucleocapsid
spike
protein
appear
time
day
onset
symptom
one
studi
date
examin
antibodi
separ
nucleocapsid
protein
spike
protein
find
gener
agreement
patient
plasma
sampl
obtain
day
symptom
onset
show
lip
assay
antibodi
nucleocapsid
spike
protein
sensit
respect
specif
antibodi
addit
studi
use
highthroughput
highli
quantit
lip
assay
may
also
help
determin
whether
rel
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
immunocompromis
nih
patient
exhibit
slower
rise
antibodi
level
plateau
lower
level
compar
immunocompet
patient
two
patient
becom
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
perform
nonetheless
current
assay
provid
highli
quantit
result
high
degre
sensit
specif
use
larger
seroepidemiolog
studi
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
use
licens
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
articl
us
govern
work
subject
copyright
usc
also
made
avail
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
